Combating Obesity in America
Health inequities affect a variety of health issues, including the chronic condition of obesity. In this episode, learn about the disparate impacts of social determinants of health (SDOH) on obesity.…
Read MoreAddressing Strain on the Healthcare Workforce
How do we effectively address the increasing strain on an already overwhelmed workforce? Guests Nikki Akparewa, RN, MSN/MPH, and Michelle Johnson, MD, MPH, describe how burnout, turnover, and early retirement…
Read MoreCommunity Initiatives to Improve Health Outcomes
Guests Rimsky Denis, MD, MPH, MBA, and Ms. Sam Hoeffler discuss community-based strategies for improving health outcomes and promoting health equity. Specific initiatives include health fairs, and barbershops, increasing communication…
Read MoreWe’re All Responsible for Lp(a)
Guest Cindy Lamendola, MSN, NP, FAHA, FPCNA, describes the impacts of elevated Lp(a) on the body. Current clinical trials and the necessity of including diverse participants are described, as well…
Read MoreLurking Lp(a): Hiding Just Below the Surface
While Lp(a) levels are generally hereditary in nature, other factors can cause elevated levels. Learn about current guidelines-directed medical therapies, and how guests Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, and…
Read MoreLp(a): Closer to Home Than You Think
Guests Kathy Byrne, MSN, CRNP, CCRN.,and Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, describe the most common genetic dyslipidemia–elevated lipoprotein (a), or Lp(a). The discussion includes testing for Lp(a)–especially for family…
Read MoreRare Arrhythmias: Do You Know What to Look For?
Only 20% of patients with atrial fibrillation are symptomatic for all their AFib episodes. Guest Dan Sorajja, MD, FACC, FHRS describes AFib diagnosis and patient-based treatment decisions for AFib. Dr.…
Read MoreAntiplatelet Therapy in CVD Prevention
Applying guidelines-directed therapies for antiplatelets and antithrombotics requires balancing the risks of cardiovascular events and the risk of bleeding. Guest Erin Michos, MD, MHS, FACC, FAHA, FASE, FASCP, describes the…
Read MorePAD: Diagnosis and Management of an Often-Silent Condition
An estimated 8.5 million adults over the age of 40 have PAD, yet up to half have no symptoms. Guest Lola Coke, PhD, ACNS-BC, FAHA, FPCNA, FAAN, describes how the…
Read MoreHypertrophic Cardiomyopathy: Diagnosis, Treatment, and Team-Based Care
Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart condition. Typical symptoms, testing, treatment options, and the role of genetic counseling and referrals to a Center of Excellence in HCM…
Read More